Modern herbal medicine for cough in children

Despite significant advances in the diagnosis and treatment of acute and chronic respiratory pathology accompanied by cough, the development of algorithms for choosing the optimal therapeutic strategy is one of the pressing problems of clinical pediatrics. In recent years, there has been a growing interest in herbal medicine as a supplement to traditional methods of treating respiratory diseases. This is due not only to the safety of herbal preparations, but also to their ability to have a complex effect on the body, which is especially important in pediatric practice. In this context, phytotherapy is a promising direction. Particular attention is paid to herbal preparations based on ivy extract (Hedera helix), which contain various biologically active components that provide a complex and multidirectional effect. Modern data confirm the advisability of including ivy extract-based drugs in the complex therapy of respiratory infections in children, due to their high efficiency and favorable safety profile. Ivybased preparations are used as an expectorant in the treatment of infectious and inflammatory diseases of the upper and lower respiratory tract, possessing proven effects such as secretolytic, mucolytic, bronchospasmolytic and anti-inflammatory action. Herbal preparations based on ivy extract can be used in various forms – syrup, drops, which allows you to choose the most convenient and acceptable option for children of different ages. Thus, promising results and detailed study of the effects of herbal medicines based on ivy extracts serve as a basis for their recommendation as part of the complex therapy of cough in children.

1. Blokhin BM, Lobushkova IP, Roshchina AK, Kuznetsov AYu, Mirzoev TKh. Diagnostics, tactics and methods of treatment of cough in children. RMJ. 2015;23(3):169–173. (In Russ.) Available at: https://www.rmj.ru/articles/obshchie-stati/Diagnostika_taktika_i_metody_lecheniya_kashlya_u_detey/.

2. Melnikova IM, Udaltsova EV, Mizernitskiy YuL. Algorithms for differential diagnosis of diseases accompanied by protracted and chronic cough in children. Pediatriya – Zhurnal im G.N. Speranskogo. 2018;97(2):8–18. (In Russ.) https://doi.org/10.24110/0031-403X-2018-97-2-8-18.

3. Mizernitskiy YuL, Melnikova IM. Persistent and prolonged cough in children: differential diagnosis and treatment algorithms. Meditsinskiy Sovet. 2019;(17):58–75. (In Russ.) https://doi.org/10.21518/2079-701X-2019-17-58-75.

4. Morice A, Kardos P. Comprehensive evidence-based review on European antitussives. BMJ Open Respir Res. 2016;3(1):e000137. https://doi.org/10.1136/bmjresp-2016-000137.

5. Jurca M, Ramette A, Dogaru CM, Goutaki M, Spycher BD, Latzin P et al. Prevalence of cough throughout childhood: A cohort study. PLoS ONE. 2017;12(5):e0177485. https://doi.org/10.1371/journal.pone.0177485.

6. Galway NC, Shields MD. The child with an incessant dry cough. Paediatr Respir Rev. 2019;30:58–64. https://doi.org/10.1016/j.prrv.2018.08.002.

7. Gilchrist FJ. An approach to the child with a wet cough. Paediatr Respir Rev. 2019;31;75–81. https://doi.org/10.1016/j.prrv.2018.11.002.

8. Jin HJ, Kim CW. Understanding the Impact of Chronic Cough on the Quality of Life in the General Population. Allergy Asthma Immunol Res. 2020;12(6):906–909. https://doi.org/10.4168/aair.2020.12.6.906.

9. Bergmann M, Haasenritter J, Beidatsch D, Schwarm S, Hörner K, Bösner S et al. Coughing children in family practice and primary care: A systematic review of prevalence, aetiology and prognosis. BMC Pediatr. 2021;21:260. https://doi.org/10.1186/s12887-021-02739-4.

10. Ahmad SR, Iyer VN. The Evolving Clinical Practice of Chronic Cough. Mayo Clin Proc. 2022;97(6):1164–1175. https://doi.org/10.1016/j.mayocp.2022.02.005.

11. Chung KF, McGarvey L, Song WJ, Chang AB, Lai K, Canning BJ et al. Cough hypersensitivity and chronic cough. Nat Rev Dis Primers. 2022;8(1):45. https://doi.org/10.1038/s41572-022-00370-w.

12. Weinberger M. Chronic Cough and Causes in Children. J Clin Med. 2023;12(12):3947. https://doi.org/10.3390/jcm12123947.

13. Weinberger M, Buettner D. The Habit Cough Syndrome. Pediatr Pulmonol. 2024:59(2):260–262. https://doi.org/10.1002/ppul.26744.

14. Irwin RS, French CT, Lewis SZ, Diekemper RL, Gold PM. CHEST Expert Cough Panel. Overview of the Management of Cough: CHEST Guideline and Expert Panel Report. Chest. 2014;146(4):885–889. https://doi.org/10.1378/chest.14-1485.

15. Usta GB, Asilsoy S, Durmaz C. The assessment and management of chronic cough in children according to the British Thoracic Society guidelines: descriptive, prospective, clinical trial. Clin Respir J. 2014;8(3):330–337. https://doi.org/10.1111/crj.12076.

16. Мизерницкий ЮЛ, Мельникова ИМ. Кашель и его терапия у детей. М.: Медпрактика-М; 2020. 244 с.

17. Marseglia GL, Manti S, Chiappini E, Brambilla I, Caffarelli C, Calvani M et al. Chronic cough in childhood: A systematic review for practical guidance by the Italian Society of Pediatric Allergy and Immunology. Allergol Immunopathol. 2021;49(2):133–154. https://doi.org/10.15586/aei.v49i2.44.

18. Marseglia GL, Manti S, Chiappini E, Brambilla I, Caffarelli C, Calvani M et al. Acute cough in children and adolescents: A systematic review and a practical algorithm by the Italian Society of Pediatric Allergy and Immunology. Allergol Immunopathol. 2021;49(2):155–169. https://doi.org/10.15586/aei.v49i2.45.

19. Wark PA, Marchant JM. Cough in Children and Adults: Diagnosis, Assessment and Management (CICADA). Summary of an updated position statement on chronic cough in Australia. Med J Aust. 2024;220(9):492. https://doi.org/10.5694/mja2.52277.

20. Andrani F, Aiello M, Bertorelli G, Crisafulli E, Chetta A. Cough, a vital reflex. mechanisms, determinants and measurements. Acta Biomed. 2019;89(4):477–480. https://doi.org/10.23750/abm.v89i4.6182.

21. Mazzone SB. Neurobiology of Coughing in Children. J Clin Med. 2023;12(23):7285. https://doi.org/10.3390/jcm12237285.

22. Bonvini SJ, Belvisi MG. Cough and airway disease: The role of ion channels. Pulm Pharmacol Ther. 2017;47:21–28. https://doi.org/10.1016/j.pupt.2017.06.009.

23. Pourova J, Dias P, Pour M, Bittner Fialová S, Czigle S, Nagy M et al. Proposed mechanisms of action of herbal drugs and their biologically active constituents in the treatment of coughs: an overview. PeerJ. 2023;11:e16096. https://doi.org/10.7717/peerj.16096.

24. Taylor-Clark TE. Role of reactive oxygen species and TRP channels in the cough reflex. Cell Calcium. 2016;60(3):155–162. https://doi.org/10.1016/j.ceca.2016.03.007.

25. Zhang M, Ma Y, Ye X, Zhang N, Pan L, Wang B. TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases. Signal Transduct Target Ther. 2023;8(1):261. https://doi.org/10.1038/s41392-023-01464-x.

26. Foti Randazzese S, Toscano F, Gambadauro A, La Rocca M, Altavilla G, Carlino M et al. Neuromodulators in Acute and Chronic Cough in Children: An Update from the Literature. Int J Mol Sci. 2024;25(20):11229. https://doi.org/10.3390/ijms252011229.

27. Wei W, Liu R, ZhangTong Y, Qiu Z. The efficacy of specific neuromodulators on human refractory chronic cough: A systematic review and metaanalysis. J Thorac Dis. 2016;8(10):2942–2951. https://doi.org/10.21037/jtd.2016.10.51.

28. Murgia V, Manti S, Licari A, De Filippo M, Ciprandi G, Marseglia GL. Upper Respiratory Tract Infection-Associated Acute Cough and the Urge to Cough: New Insights for Clinical Practice. Pediatr Allergy Immunol Pulmonol. 2020;33(1):3–11. https://doi.org/10.1089/ped.2019.1135.

29. Mizernitskiy YuL, Dorovskaya NL, Melnikova IM. Prospects for the drug use based on common ivy for bronchopulmonary pathology in childhood. Meditsinskiy Sovet. 2021;(17):122–127. (In Russ.) https://doi.org/10.21518/2079-701X-2021-17-122-127.

30. Morozova SV, Rakunova EB, Sivokhin DA, Litvinova EP. Management of acute inflammatory diseases of the upper respiratory tract with cough. Meditsinskiy Sovet. 2022;16(8):34–39. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-8-34-39.

31. Cheng ZR, Chua YX, How CH, Tan YH. Approach to chronic cough in children. Singapore Med J. 2021;62(10):513–519. https://doi.org/10.11622/smedj.2021200.

32. Salm S, Rutz J, van den Akker M, Blaheta RA, Bachmeier BE. Current state of research on the clinical benefits of herbal medicines for non-lifethreatening ailments. Front Pharmacol. 2023;14:1234701. https://doi.org/10.3389/fphar.2023.1234701.

33. Malakhov AB, Shakhnazarova MD, Farber IM, Velikoretskaya MD, Shishov AYa. Modern herbal remedies in the complex treatment of respiratory diseases in children. Lechebnoe Delo. 2016;(2):22–27. (In Russ.) Available at: https://elibrary.ru/wisfnd.

34. Barnes LA, Leach M, Anheyer D, Brown D, Carè J, Lauche R et al. The effects of Hedera helix on viral respiratory infections in humans: A rapid review. Adv Integr Med. 2020;7(4):222–226. https://doi.org/10.1016/j.aimed.2020.07.012.

35. Shokry AA, El-Shiekh RA, Kamel G, Bakr AF, Sabry D, Ramadan A. Antiarthritic activity of the flavonoids fraction of ivy leaves (Hedera helix L.) standardized extract in adjuvant induced arthritis model in rats in relation to its metabolite profile using LC/MS. Biomed Pharmacother. 2022;145:112456. https://doi.org/10.1016/j.biopha.2021.112456.

36. Brezhneva TA, Samsonova ND, Popova MV, Solodukhina AA, Slivkin AI. Prospects of Ivy’s Use in Medicine. Proceedings of Voronezh State University. Series: Chemistry. Biology. Pharmacy. 2019;(1):127–141. (In Russ.) Available at: http://www.vestnik.vsu.ru/pdf/chembio/2019/01/2019-01-17.pdf.

37. Geppe NA, Kolosova NG, Farber IM, Ivanova NA, Astafieva NG. Rational Phytotherapy of Cough in Patients with Acute Respiratory Viral Infection. Pediatrics. Consilium Medicum. 2017;(3):40–44. (In Russ.) Available at: https://omnidoctor.ru/library/izdaniya-dlya-vrachey/pediatriya-consiliummedicum/ped2017/ped2017_3/ratsionalnaya-fitoterapiya-kashlyau-patsientov-s-ostroy-respiratorno-virusnoy-infektsiey.

38. Geppe NA, Denisova AR, Denisova VD, Kolosova NG, Grebeneva IV. Symptomatic treatment of cough in children. Meditsinskiy Sovet. 2023;16(17):62–67. (In Russ.) https://doi.org/10.21518/ms2023-325.

39. Ciprandi G, Tosca MA. Non-pharmacological remedies for post-viral acute cough. Monaldi Arch Chest Dis. 2021;92(1). https://doi.org/10.4081/monaldi.2021.1821.

40. Veldman LBM, Belt-Van Zoen E, Baars EW. Mechanistic Evidence of Andrographis paniculata (Burm. f.) Wall. ex Nees, Pelargonium sidoides DC., Echinacea Species and a Combination of Hedera helix L., Primula veris L./Primula elatior L. and Thymus vulgaris L./Thymus zygis L. in the Treatment of Acute, Uncomplicated Respiratory Tract Infections: A Systematic Literature Review and Expert Interviews. Pharmaceuticals. 2023;16(9):1206. https://doi.org/10.3390/ph16091206.

41. Petrovic B, Vukomanovic P, Popovic V, Ljubica Š, Buric M, Nikolic M, Đorđević S. Significance and efficacy of triterpene saponin herbal drugs with expectorant action in cough therapy. Agric For. 2022;68(3):221–239. https://doi.org/10.17707/AgricultForest.68.3.17.

42. Сорока НД, Кречмар ЕА, Орлова ЕА, Мизерницкий ЮЛ. Мукоактивная терапия и ее особенности при различных бронхолегочных заболеваниях у детей. В: Мизерницкий ЮЛ, Царегородцев АД (ред.). Пульмонология детского возраста: проблемы и решения. Вып. 12. М.: Медпрактика-М; 2012. С. 136–145. Режим доступа: https://pedklin.ru/images/images/uploads/pages/v12.pdf.

43. Mizernitskiy YuL. Efficacy and safety of dry ivy extract (Prospan®) in treatment of bronchitis in children (according to the results of ProSpiro observational study). Pediatriya – Zhurnal im G.N. Speranskogo. 2019;98(2):119–126. (In Russ.) https://doi.org/10.24110/0031-403X-2019-98-2-119-126.

44. Mizernitskiy YuL, Sulaymanov SA. Modern combined plant remedies in pulmonologist’s practice. Meditsinskiy Sovet. 2019;(11):82–88. (In Russ.) https://doi.org/10.21518/2079-701X-2019-11-82-88.

45. Baharara H, Moghadam AT, Sahebkar A, Emami SA, Tayebi T, Mohammadpour AH. The Effects of Ivy (Hedera helix) on Respiratory Problems and Cough in Humans: A Review. Adv Exp Med Biol. 2021;1328:361–376. https://doi.org/10.1007/978-3-030-73234-9_23.

46. Alkattan A, Alameer R, Alsalameen E, Almaary M, Alkhairat M, Alkhalifah A et al. Safety of English ivy (Hedera helix) leaf extract during pregnancy: retrospective cohort study. Daru. 2021;29(2):493–499. https://doi.org/10.1007/s40199-021-00415-7.

47. Greunke C, Hage-Hülsmann A, Sorkalla T, Keksel N, Häberlein F, Häberlein H. A systematic study on the influence of the main ingredients of an ivy leaves dry extract on the β2-adrenergic responsiveness of human airway smooth muscle cells. Pulm Pharmacol Ther. 2015;31:92–98. https://doi.org/10.1016/j.pupt.2014.09.002.

48. Sieben A, Prenner L, Sorkalla T, Wolf A, Jakobs D, Runkel F, Häberlein H. Alphahederin, but not hederacoside C and hederagenin from Hedera helix, affects the binding behavior, dynamics, and regulation of beta 2-adrenergic receptors. Biochemistry. 2009;48(15):3477–3482. https://doi.org/10.1021/bi802036b.

49. Wolf A, Gosens R, Meurs H, Häberlein H. Pre-treatment with α-hederin increases β-adrenoceptor mediated relaxation of airway smooth muscle. Phytomedicine. 2011;18(2-3):214–218. https://doi.org/10.1016/j.phymed.2010.05.010.

50. Sierocinski E, Holzinger F, Chenot JF. Ivy leaf (Hedera helix) for acute upper respiratory tract inections: an updated systematic review. Eur J Clin Pharmacol. 2021;77(8):1113–1122. https://doi.org/10.1007/s00228-021-03090-4.

51. Olszanecka-Glinianowicz M, Doniec Z, Schönknecht K, Almgren-Rachtan A. The herbal medicine containing of ivy leaf dry extract in the treatment of productive cough in children. Wiad Lek. 2020;73(4):668–673. Available at: https://pubmed.ncbi.nlm.nih.gov/32731694/.

52. Rashitova EL, Zakirova AM, Moroz TB, Shayapova DT, Kadriev AG, Kadriev AA. Research of effects of plant preparation with integrated action in cough therapy in school children. Meditsinskiy Sovet. 2021;(1):100–107. (In Russ.) https://doi.org/10.21518/2079-701X-2021-1-100-107.

53. Kruttschnitt E, Wegener T, Zahner C, Henzen-Bücking S. Assessment of the Efficacy and Safety of Ivy Leaf (Hedera helix) Cough Syrup Compared with Acetylcysteine in Adults and Children with Acute Bronchitis. Evid Based Complement Alternat Med. 2020;2020:1910656. https://doi.org/10.1155/2020/1910656.

54. Akhtar M, Shaukat A, Zahoor A, Chen Y, Wang Y, Yang M et al. Anti-inflammatory effects of Hederacoside-C on Staphylococcus aureus induced inflammation via TLRs and their downstream signal pathway in vivo and in vitro. Microb Pathog. 2019;137:103767. https://doi.org/10.1016/j.micpath.2019.103767.

55. Han S, Yuan R, Cui Y, He J, Wang QQ, Zhuo Y et al. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury In Vivo and In Vitro Through the PIP2/NF-κB/NLRP3 Signaling Pathway. Front Immunol. 2022;13:846384. https://doi.org/10.3389/fimmu.2022.846384.

56. Qabaha K, Abbadi J, Yaghmour R, Hijawi T, Naser SA, Al-Rimawi F. Unveiling the antibacterial and antioxidant potential of Hedera helix leaf extracts: recent findings. Can J Physiol Pharmacol. 2024;102(1):26–32. https://doi.org/10.1139/cjpp-2023-0264.

57. Núñez C, Chiatti MC, Tansella F, Coronel-Rodríguez C, Risco E. Efficacy and tolerability of SEDIFLÙ in treating dry or productive cough in the pediatric population (SEPEDIA): A pilot, randomized, double-blind, placebocontrolled, multicenter clinical trial. Clin Pediatr. 2024;63(11):1510–1519. https://doi.org/10.1177/00099228241228074.

58. Ovsyannikova EM, Korovina NA, Zakharova IN, Yurkiv IYa. Efficacy and safety of Prospan® usage in treatment of children with upper respiratory tract inflammatory diseases (based on the results of a multicenter study). Pediatriya – Zhurnal im G.N. Speranskogo. 2007;86(5):88–93. (In Russ.) Available at: https://pediatriajournal.ru/archive?show=286&section=1954.

59. Trute A, Gross J, Mutschler E, Nahrstedt A. In vitro antispasmodic compounds of the dry extract obtained from Hedera helix. Planta Med. 1997;63(2):125–129. https://doi.org/10.1055/s-2006-957627.

60. Kostev K, Völp A, Ludwig F, Strehl C, Seifert G. Association between ivy leaves dry extract EA 575 prescriptions and antibiotic use, sick leave duration, and repeated infections in adult patients. Postgrad Med. 2022;134(3):333–340. https://doi.org/10.1080/00325481.2022.2015220.

61. Martin D, Konrad M, Adarkwah CC, Kostev K. Reduced antibiotic use after initial treatment of acute respiratory infections with phytopharmaceuticals – a retrospective cohort study. Postgrad Med. 2020;132(5):412–418. https://doi.org/10.1080/00325481.2020.1751497.

62. Seifert G, Upstone L, Watling CP, Vogelberg C. Ivy leaf dry extract EA 575 for the treatment of acute and chronic cough in pediatric patients: review and expert survey. Curr Med Res Opin. 2023;39(10):1407–1417. https://doi.org/10.1080/03007995.2023.2258777.

63. Uranic N, Barbic-Zagar B. Efficacy and safety of Herbion ivy surup in patients with cough in acute bronchitis. Sovremennaya Pediatriya. 2017;(7):29–34. (In Russ.) Available at: https://med-expert.com.ua/journals/en/efficacy-safety-herbion-ivy-surup-patients-cough-acute-bronchitis/.

64. Holzinger F, Chenot JF. Systematic review of clinical trials assessing the effectiveness of ivy leaf (hedera helix) for acute upper respiratory tract infections. Evid Based Complement Alternat Med. 2011;2011:382789. https://doi.org/10.1155/2011/382789.

65. Hofmann D, Hecker M, Völp A. Efficacy of Dry Extract of Ivy Leaves in Children with Bronchial Asthma – A Review of Randomized Controlled Trials. Phytomedicine. 2003;10(2-3):213–220. https://doi.org/10.1078/094471103321659979.

66. Zeil S, Schwanebeck U, Vogelberg C. Tolerance and effect of an add-on treatment with a cough medicine containing ivy leaves dry extract on lung function in children with bronchial asthma. Phytomedicine. 2014;21(10):1216–1220. https://doi.org/10.1016/j.phymed.2014.05.006.